Helicobacter pylori infection: From gastric to systemic disease;Manifestazioni extragastriche dell'infezione da Helicobacter pylori

Recenti Progressi in Medicina

Volumn 101, Issue 1, 2010, Pages 27-33

  Gasbarrini, Giovanni ^a   Racco, Simona ^a   Franceschi, Francesco ^a   Miele, Luca ^a   Cammarota, Giovanni ^a   Grieco, Antonio ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Adenocarcinoma; Atherosclerosis; Autoimmune tiroiditis; Cytotoxin associated gene A; Gastritis; Helicobacter pylori; Hepatic encephalopathy; Idiopathic trombocytopenic purpura; MALT lymphoma; Migraine; Pre eclampsia; Raynaud's phenomenon

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTERLEUKIN 8; VASCULOTROPIN;

HELICOBACTER INFECTION; HELICOBACTER PYLORI; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE SYSTEM; IRON DEFICIENCY ANEMIA; LAMINA PROPRIA; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; REVIEW; STOMACH CANCER; STOMACH DISEASE; SYSTEMIC DISEASE;

ADENOCARCINOMA; ANEMIA, IRON-DEFICIENCY; ATHEROSCLEROSIS; DUODENAL DISEASES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIGRAINE DISORDERS; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RAYNAUD DISEASE; STOMACH DISEASES; STOMACH NEOPLASMS; THYROIDITIS, AUTOIMMUNE;

EID: 77949381732     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Gasbarrini G, Pretolani S, Bonvicini F, Gatto MR, Tonelli E, Mégraud F, et al. A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995; 36: 838-44.
2. Jiang C, Li C, Ha T, Ferguson DA Jr, Chi DS, Laffan JJ, et al. Identification of H. pylori in saliva by a nested PCR assay derived from a newly cloned DNA probe. Dig Dis Sci 1998; 43: 1211-8.
3. Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect 1993; 111: 483-90.
4. Thomas JE, Gibson GR, Darboe MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human faeces. Lancet 1992; 340: 1194-5.
5. Capurso G, Ricci R, Panzuto F, Baccini F, Passi S, Di Giulio E, et al. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter 2003; 8: 300-6.
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
7. Papa A, Danese S, Sgambato A, Ardito R, Zannoni G, Rinelli A, et al. Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa. Scand J Gastroenterol 2002; 37: 409-13.
8. Izzotti A, De Flora S, Cartiglia C, Are BM, Longobardi M, Camoirano A, et al. Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa. Carcinogenesis 2007; 28: 892-8.
9. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter 2003; 8: 227-34.
10. Danese S, Cremonini F, Armuzzi A, Candelli M, Papa A, Ojetti V, et al. Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001; 36: 247-50.
11. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2005; 125: 364-71.
12. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, et al. Aberrant. DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-71.
13. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-9.
14. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2008 Dec 24.
15. Sepulveda AR, Tao H, Carloni E, Sepulveda J, Graham DY, Peterson LE. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther 2002;16 (suppl 2): 145-57.
16. Franceschi F, Genta RM, Gasbarrini A, Gentiloni Silveri N, Gasbarrini G, Sepulveda AR. Helicobacter pylori infection and expression of the angiogenic factor platelet-derived endothelial cell growth factor by preneoplastic gastric mucosal lesions and gastric carcinoma. Dig Liver Dis 2002; 34: 621-5.
17. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
18. Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008; 13 (suppl 1): 47-57.
19. Di Girolamo AM, Perry GS, Gold BD, et al. Helicobacter pylori, anemia, and iron deficiency: relationships explored among Alaska native children. Pediatr Infect Dis J 2007; 26: 927-34.
20. Wu KS, Hsiao CC, Yu HR, et al. Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura. Acta Paediatr Taiwan 2007; 48: 263-6.
21. Bisogno G, Errigo G, Rossetti F, et al. The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 53-7.
22. Pérez Roldán F, Castellanos Monedero JJ, González Carro P, et al. Effect of Helicobacter pylori eradication on iron deficiency anemia of unknown origin. Gastroenterol Hepatol 2008; 31: 213-6.
23. Chen LH, Luo HS. Effects of H. pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H. pylori-positive chronic gastritis. World J Gastroenterol 2007; 13: 5380-3.
24. Annibale B, Capurso G, Baccini F, Lahner E, D'Ambra G, Di Giulio E, et al. Role of small bowel investigation in iron deficiency anaemia after negative endoscopic/histologic evaluation of the upper and lower gastrointestinal tract. Dig Liver Dis 2003; 35: 784-7.
25. Gasbarrini A, Franceschi F. Does H. Pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Am J Gastroenterol 2005; 100: 1271-3.
26. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004; 140: 766-7.
27. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878.
28. Rostami N, Keshtkar-Jahromi M, Rahnavardi M, et al. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol 2008; 83: 376-81.
29. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter 2007; 12: 265-73.
30. Satake M, Nishikawa J, Fukagawa Y, et al. The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007; 22: 2233-7.
31. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97: 1675-9.
32. Gasbarrini A, Serricchio M, Tondi P, Franceschi F, Ojetti V, Sanz Torre E, et al. Helicobacter pylori infection and vascular diseases. Ital J Gastroenterol Hepatol 1998; 30 (suppl 3): S307-9.
33. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, et al. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis 2005; 37: 301-8.
34. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106: 430-4
35. Fanceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinicopathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009; 202: 535-42.
36. Vcev A, Naki D, Mrden A, et al. Helicobacter pylori infection and coronary artery disease. Coll Antropol 2007; 31: 757-60.
37. Evrengul H, Tanriverdi H, Kuru O, et al. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 2007; 12: 298-305.
38. Danesh J, Appleby P. Persistent infection and vascular disease: a systematic review. Expert Opin Investig Drugs 1998; 7: 691-713.
39. Ozdogru I, Kalay N, Dogan A, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007; 62: 501-5.
40. Altintas E, Ucbilek E, Ulu O, et al. Helicobacter pylori-associated atrophic gastritis and carotid intima-media thickness: is there a link? Int J Clin Pract 2007; 61: 810-4.
41. Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol 2008; 17: 297-302.
42. Bunch TJ, Day JD, Anderson JL, et al. Frequency of Helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. Am J Cardiol 2008; 101: 848-51.
43. Badran HM, Mahfouz ME. Cytotoxin-associated gene-A bearing strains of Helicobacter pylori and atrial fibrillation due to ischemic origin: is there a link? Eur J Cardiovasc Prev Rehabil 2007; 14: 518-20.
44. Hamed SA, Amine NF, Galal GM, et al. Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008; 17: 86-94.
45. De Bastiani R, Gabrielli M, Ubaldi E, Benedetto E, Sanna G, Cottone C, et al. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 2008; 13: 274-7.
46. Gasbarrini A, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti W, et al. Raynaud's phenomenon and helicobacter pylori infection. Int J Angiol 1998; 7: 307-9.
47. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998; 43(8):1641-5.
48. Yang CS, Cao SY, He XJ, et al. Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007; 19: 422-4.
49. Abdel-Hady H, Zaki A, Badra G, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37: 1026-33.
50. Hong L, Zhao Y, Han Y, et al. Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis B related liver cirrhosis. Helicobacter 2007; 12: 306-8.
51. Ponzetto A, Cardaropoli S, Piccoli E, Rolfo A, Gennero L, Kanduc D, et al. Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy. J Hypertens 2006; 24: 2445-9.
52. Pugliese A, Beltramo T, Todros T, Cardaropoli S, Ponzetto A. Interleukin-18 and gestosis: correlation with Helicobacter pylori seropositivity. Cell Biochem Funct. 2008; 26: 817-9.
53. Franceschi F, Di Simone N, Gigante G, Roccarina D, Giupponi B, De Marco G, et al. CagA- positive strains of H. pylori cross react with trophoblast cells: a role for pre-eclampsia and polyabortivity? Digestive and Liver Disease 2009; 41 (suppl): S13.
54. Karaer A, Ozkan O, Ozer S, et al. Gastrointestinal symptoms and Helicobacter pylori infection in early pregnancy. A seroepidemiologic study. Gynecol Obstet Invest 2008; 66: 44-6.
55. Hatziveis K, Tourlakis D, Hountis P, et al. Relationship between Helicobacter pylori seropositivity and hyperemesis gravidarum with the use of questionnaire. Minerva Ginecol 2007; 59: 579-83.
56. Aytac S, Türkay C, Kanbay M. Helicobacter pylori stool antigen assay in hyperemesis gravidarum: a risk factor for hyperemesis gravidarum or not? Dig Dis Sci 2007; 52: 2840-3.
57. Kurotsuchi S, Ando H, Iwase A, Ishida Y, Hamajima N, Kikkawa F. The plausibility of Helicobacter pylori-related infertility in Japan. Fertil Steril 2008; 90: 866-8.
58. Felkner M, Suarez L, Liszka B, et al. Neural tube defects, micronutrient deficiencies, and Helicobacter pylori: a new hypothesis. Birth Defects Res A Clin Mol Teratol 2007; 79: 617-21.
59. Gasbarrini A, Franceschi F. Autoimmune diseases and Helicobacter pylori infection. Biomed Pharmacother 1999; 53: 223-6.
60. Sterzl I, Hrdá P, Matucha P, et al. Anti-Helicobacter pylori, antithyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008; 57 (suppl 1): S135-41.
61. Apan TZ, Gürsel R, Dolgun A. Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behçet's disease. Clin Rheumatol 2007; 26: 885-9.
62. Talaat M, Gad MS, Magdy EA, et al. Helicobacter pylori infection and chronic, persistent cough: is there an association? J Laryngol Otol 2007; 121: 962-7.
63. Fang TJ, Lee LA, Li HY, et al. Helicobacter pylori colonization in the larynges of patients with hoarseness. Laryngoscope 2008; 118: 389-93.
64. Najafizadeh K, Falah Tafti S, Shiehmorteza M, et al. H. pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2007; 13: 2349-51.
65. Ibrahim WH. Helicobacter pylori eradication in the management of idiopathic pulmonary fibrosis. Eur Respir J 2007; 30: 395-6.
66. Gasbarrini A, Gabrielli M, Fiore G, Candelli M, Bartolozzi F, De Luca A, et al. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia 2000; 20: 561-5.
67. Yiannopoulou KG, Efthymiou A, Karydakis K, et al. Helicobacter pylori infection as an environmental risk factor for migraine without aura. J Headache Pain 2007; 8: 329-33.